ROPEOK(SH:688619)2022-04-26 16:00Financial Performance - The company's operating revenue for Q1 2022 was ¥10,907,971.17, representing a decrease of 75.58% compared to the same period last year[5] - The net profit attributable to shareholders was -¥12,740,256.07, a decline of 711.60% year-on-year[5] - The basic and diluted earnings per share were both -¥0.07, reflecting an 800.00% decrease[6] - Total operating revenue for Q1 2022 was CNY 10,907,971.17, a decrease of 75.5% compared to CNY 44,671,575.22 in Q1 2021[22] - Net profit for Q1 2022 was a loss of CNY 13,425,828.86, compared to a profit of CNY 1,387,782.55 in Q1 2021[23] - Basic and diluted earnings per share for Q1 2022 were both CNY -0.07, compared to CNY 0.01 in Q1 2021[23] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,136,301,126.85, down 7.63% from the end of the previous year[6] - The total assets as of March 31, 2022, were CNY 2,136,301,126.85, a decrease from CNY 2,312,790,160.20 as of December 31, 2021[19] - Total liabilities as of March 31, 2022, were CNY 619,166,900.02, down from CNY 782,230,104.51 at the end of 2021[19] - The total equity attributable to shareholders was CNY 1,506,175,499.99 as of March 31, 2022, a slight decrease from CNY 1,518,915,756.06 at the end of 2021[19] Cash Flow - The net cash flow from operating activities was -¥76,015,019.07, with significant improvements in accounts receivable management noted[10] - In Q1 2022, the company reported cash inflows from operating activities of ¥83,991,654.60, an increase of 51.9% compared to ¥55,253,068.15 in Q1 2021[25] - The net cash outflow from operating activities was ¥76,015,019.07, an improvement from a net outflow of ¥124,813,050.48 in the same period last year[25] - The company's cash and cash equivalents at the end of Q1 2022 stood at ¥254,893,901.18, down from ¥378,179,211.69 at the end of Q1 2021[26] - The total cash and cash equivalents decreased by ¥522,297,333.82 during the quarter, compared to an increase of ¥206,665,421.69 in Q1 2021[26] Research and Development - Research and development expenses totaled ¥9,823,271.50, which accounted for 90.06% of operating revenue, an increase of 72.30 percentage points[6] - The company reported a significant increase in R&D expenses, totaling CNY 9,823,271.50 in Q1 2022, up from CNY 7,931,640.04 in Q1 2021, representing a 24% increase[22] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 9,974[12] - The company reported a total of 10 major shareholders, with the largest being Chen Yanxing, holding 37.80% of shares[14] - The top 10 unrestricted shareholders collectively hold significant stakes, with the largest unrestricted shareholder owning 6,492,907 shares[14] Operational Challenges - The company experienced delays in order deliveries due to supply chain instability caused by the pandemic, impacting revenue and profit recognition[10] Future Outlook - The company has not provided specific future guidance or performance outlook for the upcoming quarters[15] - The company has not reported any significant new product developments or technological advancements during this quarter[15] - There are no updates on market expansion or mergers and acquisitions in the current report[15] Accounting Standards - The company has not adopted the new accounting standards for the current year[28] Management Team - The company’s management team includes Jiang Wentao as the responsible person, Yu Limei as the accounting supervisor, and Chen Yingming as the head of the accounting institution[26]